T cell activation mediated by the TCR is triggered by a complex of an antigenic peptide with a cell surface protein encoded by the MHC. The specific control of the trimolecular interaction between a particular antigen, MHC molecule, and TCR follows a set of genetically programmed parameters . MHC polymorphisms regulate one of these parameters, termed MHC restriction, by which some MHC alleles form "permissive" complexes that permit T cell response, and other MHC alleles do not. Recent studies using murine class II MHC molecules (1-2) have demonstrated that the act of binding a peptide is necessary, but not always sufficient to trigger potentially reactive T cells; presumably, precise structural interactions between amino acids on the peptide and on the class II molecule itself are crucial for recognition. Structural variation among class II molecules can be critically important for this function . In the example of the H-26 "12 mouse, three amino acid substitutions in the class II Ia (3 chain distinguish the bm12 strain from the parental B6 strain, and apparently confer a wide variety of distinct immunologic characteristics, including alloreactivity against the parental B6, differential responsiveness to defined antigenic peptides, and differential susceptibility to experimentally induced myasthenia gravis (3-5).
T cell activation mediated by the TCR is triggered by a complex of an antigenic peptide with a cell surface protein encoded by the MHC. The specific control of the trimolecular interaction between a particular antigen, MHC molecule, and TCR follows a set of genetically programmed parameters . MHC polymorphisms regulate one of these parameters, termed MHC restriction, by which some MHC alleles form "permissive" complexes that permit T cell response, and other MHC alleles do not. Recent studies using murine class II MHC molecules (1) (2) have demonstrated that the act of binding a peptide is necessary, but not always sufficient to trigger potentially reactive T cells; presumably, precise structural interactions between amino acids on the peptide and on the class II molecule itself are crucial for recognition. Structural variation among class II molecules can be critically important for this function . In the example of the H-26 "12 mouse, three amino acid substitutions in the class II Ia (3 chain distinguish the bm12 strain from the parental B6 strain, and apparently confer a wide variety of distinct immunologic characteristics, including alloreactivity against the parental B6, differential responsiveness to defined antigenic peptides, and differential susceptibility to experimentally induced myasthenia gravis (3) (4) (5) .
As the bm12 mouse example illustrates, specific substitutions in class 11 0 chains may have dramatic consequences for immune function . Among human class II molecules, both the class II a and the class 11 0 chains in functional class II dimers potentially contribute structural variation affecting function, particularly at the HLA-DQ locus, where both a and a genes are highly polymorphic. Structural models of recognition events involving HLA class II molecules suggest that polymorphic sites on a and /3 chains potentially interact with each other, with peptide, and with TCR (6) (7) .
To evaluate the fine structural requirements ofthis interaction, we analyzed human T cell-MHC interactions in vitro by evaluating the effects of specific molecular substitutions within the class II HLA-DQ a and /3 chain components . We have previously described the use of site-directed mutagenesis on cloned human MHC genes, followed by retrovirus-mediated gene transfer into human B cell lines, as an experimental approach to the structural modeling of HLA class II molecules (8) (9) . Recently, we have generated a set of allospecific human T cell clones that distinguish among a number of closely related human MHC alleles at the HLA-DQlocus (10) . In order to map the structural constraints that account for the specificity of T cell triggering in this system, we constructed a set of human B cell lines carrying an array of systematically altered HLA-DQ molecules, and tested their ability to activate a panel of human allospecific T cells. In this study, the observed patterns of activation identify specific residues on the DQ3 chain, and specific polymorphic a-(3 chain interactions within the expressed HLA molecule, which are critical for activation.
Materials and Methods
Cell Lines and mAbs. All EBV transformed B-lymphoblastoid cell lines (B-LCLs)' were homozygous lines obtained from the 9th and 10th International Histocompatibility Workshops. B-LCLs that were used for transfections were MAT, KT3, and IBW9. The HLA genotype and DQallospecificity of these cell lines are as follows: (DQce nomenclature used is similar to that ofKwok et al. [111 and Horn et al. [121; see also Table 1 ) MAT is DR3, DQ2a(DQA4), DQ2(3, DQw2; KT3 is DR4, DQ3a(DQA3), DQ40, DQw4; IBW9 is DR7, DQ7a(DQA2), DQ2R, DQw2. HLA-homozygous B-LCLs that were used as postive controls for DQw3 allospecific T cell clones were PF97387, PE117, DBB, and DKO . PF97387 is DR4, DQ3a, DQ70(DQ3 .ls), DQw7; PE117 is DR4, DQ3a, DQ80(DQ3 .20), DQw8; DBB is DR7, DQ7a, DQ9S(DQ3.30), DQw9; and DKB is DR9, DQ3a, DQ90(DQ3.3a), DQw9. DQw7, DQw8, and DQw9 are all subtypes of the DQw3 family. Murine mAb used included mAb IVD12 (DQw3-specific) (13), mAb 159.1 (DQw7-specific), and 200 .1 (DQw8-specific) (9) .
Retrovirus-mediated Gene Transfer andExpression. The construction ofthe mutagenized DQ3 .2 cDNAs DQ3 .2m13, DQ3 .2m26, DQ3 .2m45, and DQ3 .2m57 by site-directed mutagenesis has been described (reference 9, Fig. 1 ). The oligomer 5'-GGGCCGCCTGATGCCGAGTAC-3' was used to construct DQ3 .2m45,57 cDNA from the DQ3 .2m45 cDNA using the same protocol . All mutagenized cDNAs were shuttled into retroviral vectors that carried a neomycin phosphotransferase gene with the cDNA under the regulatory control ofCMVIE promoter. Virus-producing fibroblasts generated from the HLA retroviral vectors were used to infect B-LCLs by means ofcocultivation . The detailed protocols for construction ofretroviral vectors, generation of virus-producing cells, and infection of B-LCLs have been described (8) .
Human T Cell Proliferation. Proliferative T lymphocytes reactive with cells expressing DQw3 were generated by in vitro priming between stimulator and responder PBMC and cloned by limiting dilution (14) . Clone IE6 was derived by priming between HLA-identical siblings who differed for the HLA-DR, DQ, DP segment ofone haplotype due to intra-HLA recombination (10) . Clone IE6 is specific for DR7, DQw9, Dwll cells, and does not react with cells expressing DR9, DQw9, Dw23 (Mickelson, E., S. Masewicz, G. Nepom, and J . Hansen, manuscript submitted for publication) . Clones 21J and 64B were derived from a priming between a DR4, DQw8, Dw4 homozygous stimulator cell and a DR1,4; DQwl,w7 ; Dwl,w4 responder cell (15) . Clone 21J is specific for DQw8 and DR9, DQw9, Dw23 cells, and does not react with cells expressing DR7, DQw9, Dwll; clone 64B is specific for DQw8 cells only. Activity of each clone is blocked by anti-DQ, but not anti-DR, antibodies (Mickelson, E., et al., manuscript submitted for publication) .
T cell clones were screened for specific responses by assaying 10' cells for proliferative activity after incubation with 2 .5 x 10' irradiated (2,500 rad) stimulator cells in 0.15 ml of complete medium in Vbottomed microtiter plates for 66 h. During the final 18 h ofincubation, I p,Ci of ['Hlthymidine (SA = 6.7 Ci/mM) was added and the activity per culture was measured as counts per minute (cpm). Stimulatory activity due to the presence of transfected class II genes is expressed as Acpm in which the mean cpm in cultures with untransfected LCL is subtracted from the mean cpm in cultures with DNA transfected into the same LCL ; all determinations were in triplicate . Significance values were determined by comparisons between LCL transfected with the wild-type DQ3 .2 gene and the same LCL transfected by mutant DQ3 .2 genes, performed by Student's 1-test . For clone 64B, assays were performed in the presence of 1 U/ml IL-2.
Cytofluorometric Analysis. 5 x 105 cells were incubated with the appropriate mAb for 1 h at 4°C. The cells were then washed and incubated with FITC-labeled sheep anti-mouse Ig for 1 h at 4°C . After additional washing, cells were fixed with 2 % paraformaldehyde and analyzed on a flow cytometer (No. 440 ; Becton Dickinson and Co., Mountain View, CA) .
Results
Characterization ofHLA-DQ3.2 Expression and Recognition Patterns. We chose the HLA-DQ3 .2 (DQw8) molecule as the focus of this study for several reasons : The HLA-DQ3 .2 gene is prevalent in the population, present in N18% of Caucasians. HLA-DQ3 .2 is a member of a closely related family of DQw3-associated alleles that have distinct genetic and immunologic properties : The HLA-DQ3 .2 gene is strongly associated with HLA-DR4 ; the HLA-DQ3 .3 gene, which is strongly associated with HLA-DR9 and DR7, differs from DQ3.2 by only one amino acid substitution (Fig. 1) . The HLA-DQ3 .1 gene, which differs from the DQ3 .2 by four amino acid substitutions in the first domain, is associated with HLA-DR4, DR5, and DR8 . On different DR4 haplotypes, which in some cases may carry a DQ3.2 gene and in other cases a DQ3 .1 gene, these DQallelic differences are presumed to account for major functional differences, including a significantly different risk of disease susceptibility for diabetes mellitus (16) (17) (18) (19) (20) (21) .
cDNA from the DQ3.2 gene was inserted into a retroviral expression vector and transfected into human B cell lines with different endogenous DQa genes. We chose recipient cell lines representing three ofthe major four families ofDQa alleles (Table  I) , termed DQ2a, 3a, and 7a (11, 12, (22) (23) . Reactivity patterns of these transfected human B-LCLs with a panel of DQreactive mAbs and T cell-allospecific clones are shown in Table II . First domain amino acid sequences for the DQ3 alleles and site-directed substitutions used in this study. DQa alleles cluster into the four major families shown ; synonyms that have also been used in the literature (12) are indicated, along with proposed WHO nomenclature revisions . HLA-DR specificities in parentheses represent rare linkage patterns . DQla polypeptides do not form stable bimolecular dimers with DQ25 or DQ35 polypeptides (11) , and were therefore not tested in this study .
Each ofthree transfected B-LCLs expressed an intact HLA class II dimer on their cell surface containing the DQ3 .2/3 chain, as detected by indirect immunofluorescence with anti-DQw3 mAb IVD12 and anti-DQw3.2 mAb GS200.1, indicating the presence of the 3.20 polypeptide in all lines, apparently complexed to endogenous a chains (8) . Among the T cell clones tested, three different anti-DQw3-specific clones, with different fine specificities distinguishing DQw7, DQw8, and DQw9, also reacted with the transfected B-LCL panel. None of these T cells responded to sham-infected LCL that had been transfected with a control vector (not shown) . However, some combinations of DQa chains complexed with the DQ3.20 chain were sufficient to stimulate each clone: Expression of the DQ3.20 chain in DQ7a + cells stimulated only clone 1E6, not clones 21J or 64B, and reciprocally the DQ3.2a chain expressed in DQ2a+ or 3a+ cells stimulated only clones 21J or 64B, but not clone 1E6. For both clones 21J and 64B, the homologous 3a/3 .20 dimer stimulated proliferation better than the 2a/3 .20 dimer (Table II) .
Contributions of0 Chain Epitopes to T Cell Recognition. Fig. 1 summarizes the amino acid sequences ofthe polymorphic first domain from DQf3 chains encoding the DQw7, DQw8, and DQw9 specificities. Also shown in Fig. 1 are the corresponding residues encoded by a panel ofDQ3 analogs, which we constructed using site-directed mutagenesis ofthe DQf83.2 cDNA . Mutations were introduced at key polymorphic residues corresponding to the sites which distinguish among the DQw7, w8, and w9 specificities . In one case (i.e., m45,57) more than one residue was substituted by site-directed mutagenesis. Each of these 0 chain genes were introduced into B-LCL with an endogenous DQ3a gene and tested for stimulation ofthe alloreactive T cell panel (Table  III) . Since the 3a/Uf dimer mimics the normal linkage pattern for the DQ3.2 gene, this experiment was designed to focus on the contribution of the substitutions within the (3 chain on T cell recognition. Clone 6413, allospecific for DQw8 (i.e., 3a/3 .20), had diminished reactivity to transfectants with substitutions at codons 13, 26, or 57 of the DQ3 .2a chain. In contrast, none of these substitutions altered the reactivity of clone 21J, which has a slightly broader reactivity pattern (i.e., DQw8 + DQw9), and none reconstituted the activity of clone IE6. DQa Chain Contributions to TCell Reactivity Patterns. When this same panel ofmutagenized a genes was introduced into different B-LCL for DQ3 expression with heterologous DQa chains, interactions between DQa chains and specific a chain substitutions became apparent. The DQ3 .2m26 a chain (which had failed to stimulate clone 64B when paired with a DQ3a chain), nevertheless stimulated clone 64B when paired with a DQ2a chain (Table IV) . This activity contrasted markedly with the diminished stimulatory activity of transfected DQ3.2m13, m45, and m57, none of which stimulated the 64B clone when expressed in the DQ2a cells. In contrast, DQ3 .2m26, as well as DQ3.2m45 and DQ3.2m57, failed to stimulate clone 21J when expressed in DQ2a + cells, even though they were entirely competent for stimulation in the DQ3a cells. Interestingly, DQ3.2m26 also was sufficient to stimulate clone 64B in the context of DQ7a . With DQ7a, however, but not with DQ2a, mutations at codon 57 also reconstituted stimulatory activity for clone 64B. Clone 21J did not react with any of the DQ7a associated dimers, and clone IE6 reacted with all, although with diminished reactivity on dimers containing DQ3.2m45 or DQ3.2m57. mAb-Determined Epitopes Associated with DQw3 Are Primarily # Chain Associated. Several murine anti-DQw3-associated mAbs were tested by indirect immunofluorescence for reactivity against each of the DQa and a chain combinations reported here . In all cases, reactivity patterns for each mAb were consistent with previously reported specificities regardless of the associated DQa chain. These reactivity patterns are summarized in Table IV . The presence of a glutamic acid residue at codon 45 of the DQ3 .2 molecule accounts for the epitope corresponding to DQw7, recognized by mAb 159 .1, which was previously termed "TA10" or "DQw3.1" (24, 25) . Reciprocally, presence of a glycine at this position corresponds to the DQw8 specificity, previously designated DQw3 .2, recognized by mAb 200.1 and IIB3 (1, 9, 18). These epitopes, as well as the broad DQw3 epitope recognized by mAbs IVD12, 17 .15, and 100.1, remained intact on the panel of /3 chains transfectants associated with either DQ2a, 3a, or 7a, and therefore appeared to be "blind" to the a chain contribution .
Discussion
The extreme genetic polymorphism of the human MHC translates into a diverse array of polymorphic class I and class II cell surface molecules. Since class TI HLA molecules are composed of dimers of a and S chains, each of which may be polymorphic, there is a potential element of bimolecular interaction in the expressed structure. Particularly in heterozygous individuals, where trans-associated class II dimers form (26) , there is the potential for an identical gene product, such as the DQ3.2 0 chain, to contribute to different recognition elements based on dimerization with different DQa chains. When this level of structural and functional heterogeneity is augmented by structural polymorphisms within the a and S chains themselves, there is potential for an extremely wide degree of variation among different, even haploidentical, individuals . To begin to understand some of the structural parameters and constraints on this diversity, we constructed a panel of 18 transfectants, expressing combinations of S chains and a chains that distinguish the expressed DQ molecules of the DQw3-related family. Site-directed mutagenesis was used to introduce 0 chain substitutions at single codons, and the resulting mutagenized DQ(3 genes were expressed in human B cell lines to form stable DQ dimers with endogenous DQ2a, 3a, and 7a chains.
In these experiments, the stimulatory capacity of a particular class II dimer in assays of alloreactive T cell clone stimulation was dependent on a-0 interactions .
This dependence on complex epitopes for T cell recognition contrasted with the serologically defined epitopes studied, which were determined by the a chain alone. Interactions between class II a and (3 chains have been inferred in the past by experiments in which T cells are apparently restricted to heterozygotes, implying the possibility of a trans-associated class II dimer (27, 28) and by structural studies in which trans-associated a and a chains do (26) or do not (11, (29) (30) pair and form stable dimers . We directly demonstrate the potential for such interactions to dictate T cell activation, illustrated by variation in recognition of DQ3 .2-related epitopes .
The recent structural elucidation of the three-dimensional structure of an HLA class I molecule offers the opportunity for considerable insight into the precise molecular contributions to these interactions . In the HLA-A2 class I crystallographic structural analysis (31) , and in the hypothetical class 11 model based on homologies between class I and class II genes (6), several sites for potential interaction between a and /3 chains occur. In addition, both a and /3 chains have direct and indirect contact points with the predicted antigen (peptide) binding site of the class II molecule . Allorecognition is most likely a composite of clonal events, some of which involve direct triggering of allospecific TCR by polymorphic class 11 molecules and some of which require a peptide bound by the class II molecule . In this sense, the clonal reactivity patterns analyzed in our studies represent discrete examples of antiDQw3 allorecognition events . By comparing our results to the class II structural model, these examples suggest interpretations for class II TCR interactions that involve both direct and peptide-dependent activation .
In the context of this molecular model, the amino acid substitutions introduced by mutagenesis in our experiments highlight potential sites of molecular interactions. Residues 26 and 57 showed evidence of direct or indirect interaction with DQa chains : Recognition by clone 64B was dependent on the presence of specific DQf83.2 residues at codons 13, 26, and 57, when paired with a DQ3a chain. Substitution at each of those positions resulted in loss of activity. However, recognition by clone 64B of the substitution at residue 26 could be reconstituted in the context of DQ2a or DQ7a . This argues against a model in which clone 64B recognizes two epitopes (i .e ., at codon 26 on the a chain and an additional polymorphic site on DQ3a) and argues for a model in which there is some conformational synergy between polymorphisms on the a chain and codon 26 on the /3 chain. This synergy between residue 26 and the a chain may well be due to indirect molecular interactions, possibly involving peptide binding by the class II molecule, since residue 26 is predicted to lie on the opposite side of the postulated peptide binding groove from the a chain helix, in current models of class II structure.
Substitution of an aspartic acid at codon 57 showed a similar a/)3 interaction effect, in that the DQ7a/3 .2m570 dimer was stimulatory for clone 64B whereas the wildtype DQ7a/DQ3 .2R dimer was not. Furthermore, a complex role for residue 57 in a chain interactions was suggested by results with clone 1E6. Reactivity of clone IE6 was heavily dependent upon an appropriate DQa chain, since stimulation was only seen with DQ7a . While all DQ chains tested stimulated clone 1E6 in DQ7a+ cells, substitutions at codons 57 and 45 had reduced stimulatory activity. Again, this is more likely to be related to conformational effects of a//3 interaction rather than on the contribution of a specific a chain epitope, since the "double mutant" with substitutions at both codons 45 and 57 reconstituted clone 1E6 activity. A role for residue 57 in ct/(3 interactions has previously been postulated, based on the structural model mentioned above, in which an aspartic acid at position 57 would potentially form a stable "salt bridge" with an invariant arginine at residue 79 of the a chain. Since the codon 57 substitutions in our studies generated an aspartic acid replacement for an alanine, such a potential direct a/o interaction could account for the observed structural synergy.
With clone 64B, but not 21J or 1E6, substitution at DQ/3 codon 13 also interfered with stimulatory activity, indicating a more limited potential for this residue contributing to key epitopes . Although speculative, the postulated placement of residue 13 in the class II model in the "floor" of the peptide binding site might suggest that activity of alloreactive clone 64B is particularly subject to influence by bound peptides. In contrast, substitution at DW codon 45 (postulated to be "outside" the peptide contact regions) was responsible for the gain and loss of the major serologically defined allospecificities (DQw7, DQw8) associated with these DQ(6 molecules, and also contributed to some, but not all, of the T cell-defined epitopes .
Although the T cell recognition epitopes illustrated in this study are complex, it is apparent that single residue substitutions in most cases are sufficient to alter or abolish reactivity. This suggests that fairly simple structural modifications of class II molecules may have profound functional effects. In previous studies, mutagenesis of the HLA-A2 molecule has been used to map sites of potential interaction with antigen or cytolytic T cells; in these studies, as in ours, single amino acid substitutions are in some cases sufficient to alter T cell reactivity (32) . Limited studies of murine class II molecules, based on selection of functionally defective class II variants, have similarly implicated specific potential sites of interaction critical for interactions with antigen and/or T cells (5, 33) . In addition, a recent report demonstrated that a number of discrete A(3 substitutions heavily influenced by Aa polymorphisms contributed to murine allorecognition, analogous to the studies reported here (34) .
Our studies of T cell clones that recognize DQw3-related specificities indicate both a chain and (3 chain contributions to specificity. Furthermore, all three clones studied have major differences in their fine specificity, even though 64B and 21J were clones derived from the same individual during the same in vitro priming experiment (Mickelson, E., et al ., manuscript submitted for publication) . Although we analyzed a small sample, our results indicate that the T cell response, even to fairly similar epitopes, is likely to be diverse. The relative contributions of HLA class II a chain and ,Q chain polymorphisms to T cell recognition, and consequently to an in vivo immune response, are likely to be extremely heterogeneous .
The DQ3.2)3 gene used as a model in these studies has been implicated as the most likely candidate for an HLA-associated disease susceptibility gene in type I diabetes (IDDM) (17, 35) . Individuals who carry a DQ3.2 gene are more than eightfold more likely of developing IDDM than individuals without a DQ3.2 gene. Although the mechanisms whereby the 3.2 gene is associated with IDDM are not known, they are assumed to be related either to an antigen-presenting function associated with autoimmunity or to a role in T cell repertoire selection during thymic develop-ment. In any event, since the DQ3 .1 gene is not associated with IDDM, a number of investigators have speculated on the potential functional relevance of residues at codons 13, 26, 45, and 57, which distinguish DQ3.2 from DQU (9, 12, 20, (36) (37) (38) (39) . From our studies, it is apparent that the distinction between DQ3.2 and DQU, as recognized by the immune system, depends on an interaction between multiple sites on the /3 chain, with contributions from the a chain as well. Since single residue substitutions can abolish or restore T cell recognition as demonstrated in these studies, it is conceivable that single residue substitutions can be critical for disease pathogenesis. However, detailed molecular modeling with class II structural mutants, putative peptide antigens, and candidate T cell clones will be necessary in order to identify the constellation of interacting factors that coincide to trigger HLA-associated pathogenic events in IDDM. Summary 18 transfected cell lines were generated that expressed distinct DQmolecules related to the serologically defined HLA-DQw3 specificity. These transfectants were constructed using site-directed mutagenesis to introduce nucleotide substitutions into DQ3.20 cDNA, followed by retrovirus-mediated gene expression ofthe mutagenized genes in human B cell lines with different endogenous DQa chains. The capacity of particular class II dimers to stimulate alloreactive T cell clones was investigated. T cell activation was found to be dependent on both DQa and DQf3 chains. In some cases, single amino acid substitutions at codons 13, 26, 45, or 57 of the DQ chain were sufficient to dramatically alter T cell reactivity; T cell recognition of these substitutions, however, was strongly influenced by the a chain polymorphisms present in the stimulatory class II dimer. Both gain and loss of major serologic and cellular specificities associated with specific DQw3+ alleles were observed with a limited array of site-directed substitutions .
